/PRNewswire/ Biosyngen, an immune-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma treatment, today announced.
New state-of-the-art facility to develop immunotherapy assets to address unmet needs in cancer treatmentSINGAPORE - Media OutReach - 28 June 2023 – Biosyngen, an.